Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compugen (CGEN) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Compugen (CGEN) over the last 9 years, with Q3 2025 value amounting to $10.7 million.

  • Compugen's Current Deferred Revenue fell 3292.07% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year decrease of 3292.07%. This contributed to the annual value of $9.6 million for FY2024, which is 1360.66% down from last year.
  • Per Compugen's latest filing, its Current Deferred Revenue stood at $10.7 million for Q3 2025, which was down 3292.07% from $29.6 million recorded in Q2 2025.
  • Compugen's Current Deferred Revenue's 5-year high stood at $29.6 million during Q2 2025, with a 5-year trough of $9.6 million in Q1 2025.
  • In the last 3 years, Compugen's Current Deferred Revenue had a median value of $11.0 million in 2023 and averaged $13.6 million.
  • Examining YoY changes over the last 5 years, Compugen's Current Deferred Revenue showed a top increase of 16299.32% in 2025 and a maximum decrease of 3292.07% in 2025.
  • Over the past 3 years, Compugen's Current Deferred Revenue (Quarter) stood at $11.1 million in 2023, then decreased by 13.61% to $9.6 million in 2024, then grew by 10.83% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $29.6 million for Q2 2025, and $9.6 million during Q1 2025.